Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) EBITDA Margin (2022 - 2024)

Historic EBITDA Margin for Solid Biosciences (SLDB) over the last 3 years, with Q4 2024 value amounting to 53194.67%.

  • Solid Biosciences' EBITDA Margin changed N/A to 53194.67% in Q4 2024 from the same period last year, while for Dec 2024 it was 38155.29%, marking a year-over-year decrease of 480033800.0%. This contributed to the annual value of 38155.29% for FY2024, which is N/A changed from last year.
  • As of Q4 2024, Solid Biosciences' EBITDA Margin stood at 53194.67%.
  • In the past 5 years, Solid Biosciences' EBITDA Margin registered a high of 53194.67% during Q4 2024, and its lowest value of 411.44% during Q2 2022.
  • Over the past 3 years, Solid Biosciences' median EBITDA Margin value was 29926.53% (recorded in 2024), while the average stood at 30335.37%.
  • Over the last 5 years, Solid Biosciences' EBITDA Margin had its largest YoY gain of 18047200bps in 2024, and its largest YoY loss of 18047200bps in 2024.
  • Over the past 3 years, Solid Biosciences' EBITDA Margin (Quarter) stood at 411.44% in 2022, then soared by 6534bps to 26471.07% in 2023, then skyrocketed by 101bps to 53194.67% in 2024.
  • Its EBITDA Margin was 53194.67% in Q4 2024, compared to 42904.88% in Q3 2024 and 31577.27% in Q2 2024.